DCDa Cao

Da Cao

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Da Cao has a total of 13 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Navigating Anticoagulation Decisions in Atrial Fibrillation and Frailty Comorbidity

    by Ziyang Wu, Da Cao, Chengchun Tang

    Frailty is highly prevalent in older patients with atrial fibrillation (AF), complicating anticoagulation decisions due to the dual elevation of both stroke and bleeding risks. This narrative review provides a framework to guide these decisions. We propose a three-step approach: (1) systematically assess frailty using a validated tool to stratify patients into risk categories; (2) translate this stratification into therapeutic choices, generally favoring direct oral anticoagulants (DOACs) over warfarin, with data suggesting a favorable bleeding profile for apixaban in frail populations, but routine switching to a DOAC should be avoided in frail patients who are stable on warfarin with good time in therapeutic range; and (3) consider specific alternatives, such as very-low-dose edoxaban, for patients with severe frailty or a prohibitive bleeding risk, while noting that this strategy should be applied within its specific regulatory and clinical context. The net clinical benefit of anticoagulation, defined as the absolute risk reduction in ischemic stroke offset by the absolute risk increase in major bleeding, diminishes with increasing frailty severity and may vanish in the most severe stages. Clinical decisions must therefore integrate dynamic frailty reassessment, multidisciplinary collaboration, and patient preferences. This review underscores a shift from purely guideline-driven to patient-value-driven individualized anticoagulation strategies in frail older adults with AF.

  • Mild Hypothermia Alleviates Complement C5a-Induced Neuronal Autophagy During Brain Ischemia–Reperfusion Injury After Cardiac Arrest

    by Ling Wang, Yuanyuan Sun, Fang Kong, Yi Jiang, Mengmeng An, Beibei Jin, Da Cao, Ruifang Li, Xiaolan Guan, Shuangshuang Liang, et al.

    After restoration of spontaneous circulation (ROSC) following cardiac arrest, complements can be activated and excessive autophagy can contribute to the brain ischemia–reperfusion (I/R) injury. Mild hypothermia (HT) protects against brain I/R injury after ROSC, but the mechanisms have not been fully elucidated. Here, we found that HT significantly inhibited the increases in serum NSE, S100β, and C5a, as well as neurologic deficit scores, TUNEL-positive cells, and autophagic vacuoles in the pig brain cortex after ROSC. The C5a receptor 1 (C5aR1) mRNA and the C5a, C5aR1, Beclin 1, LC3-II, and cleaved caspase-3 proteins were significantly increased, but the P62 protein and the PI3K/Akt/mTOR pathway-related proteins were significantly reduced in pigs after ROSC or neuronal oxygen–glucose deprivation/reoxygenation. HT could significantly attenuate the above changes in NT-treated neurons. Furthermore, C5a treatment induced autophagy and apoptosis and reduced the PI3K/Akt/mTOR pathway-related proteins in cultured neurons, which could be reversed by C5aR1 antagonist PMX205. Our findings demonstrated that C5a could bind to C5aR1 to induce neuronal autophagy during the brain I/R injury, which was associated with the inhibited PI3K/Akt/mTOR pathway. HT could inhibit C5a-induced neuronal autophagy by regulating the C5a–C5aR1 interaction and the PI3K/Akt/mTOR pathway, which might be one of the neuroprotective mechanisms underlying I/R injury. Graphical Abstract The C5a receptor 1 (C5aR1) mRNA and the C5a, C5aR1, Beclin 1, LC3-II, and cleaved caspase-3 proteins were significantly increased, but the P62 protein and the PI3K/Akt/mTOR pathway-related proteins were significantly reduced in pigs after ROSC or neuronal oxygen–glucose deprivation/reoxygenation. Mild hypothermia (HT) could significantly attenuate the above changes in NT-treated neurons. Furthermore, C5a treatment induced autophagy and apoptosis and reduced the PI3K/Akt/mTOR pathway-related proteins in cultured neurons, which could be reversed by C5aR1 antagonist PMX205. Proposed mechanism by which HT protects against brain I/R injury by repressing C5a–C5aR1-induced excessive autophagy. Complement activation in response to brain I/R injury generates C5a that can interact with C5aR1 to inactivate mTOR, probably through the PI3K-AKT pathway, which can finally lead to autophagy activation. The excessively activated autophagy ultimately contributes to cell apoptosis and brain injury. HT may alleviate complement activation and then reduce C5a-induced autophagy to protect against brain I/R injury. HT, mild hypothermia; I/R, ischemia reperfusion.